首页 | 本学科首页   官方微博 | 高级检索  
     

吸入糖皮质激素治疗稳定期慢性阻塞性肺病的临床研究进展和评价
引用本文:王建丽. 吸入糖皮质激素治疗稳定期慢性阻塞性肺病的临床研究进展和评价[J]. 中国医院用药评价与分析, 2006, 6(4): 203-205
作者姓名:王建丽
作者单位:北京大学第三医院呼吸科,北京市,100083
摘    要:目的:探讨糖皮质激素对稳定期慢性阻塞性肺病的治疗情况,以期为临床应用提供参考。方法:收集近年来有关糖皮质激素对稳定期慢性阻塞性肺病的临床研究结果作一回顾性分析。结果及结论:目前,糖皮质激素在治疗稳定期慢性阻塞性肺病方面的应用正在增多,但是其疗效是否确切还有待进一步的研究证实,而治疗费用、不良反应等相关因素都有待广泛观察。

关 键 词:糖皮质激素  慢性阻塞性肺病  临床疗效  应用评价
文章编号:1672-2124(2006)04-0203-03
修稿时间:2006-03-07

Glucocorticoid Inhalation for Chronic Obstructive Pulmonary Disease (COPD) at Stationary Phase: Clinical Research Progress and Evaluation
WANG Jianli. Glucocorticoid Inhalation for Chronic Obstructive Pulmonary Disease (COPD) at Stationary Phase: Clinical Research Progress and Evaluation[J]. Evaluation and Analysis of Drug-Use in Hospital of China, 2006, 6(4): 203-205
Authors:WANG Jianli
Abstract:OBJECTIVE:To discuss the clinical efficacy of glucocorticoid for chronic obstructive pulmonary disease(COPD) at stationary stage so as to provide references for it application in the clinic.METHODS: Outcome of recent clinical research on glucocorticoid for COPD at stationary stage was reviewed retrospectively.RESULTS & CONCLUSION: The application of glucocorticoid for COPD at stationary stage has been increasing,but its clinical efficacy remains to be further confirmed,and its associated factors such as the treatment costs,ADRs,etc.should be further investigated.
Keywords:glucocorticoid  chronic obstructive pulmonary disease(COPD)  clinical efficacy  application evaluation
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号